Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors
Conclusion We report the clinical and genomic landscape of a patient with MPTs who had no identifiable unique somatic or germline mutations to explain her predilection to cancer. The treatment course and overall prognosis for this patient is important for understanding future cases with unrelated, metachronous MPTs, the occurrence of which cannot always be explained by underlying genetic mechanisms.
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research
More News: Biology | Brain | Brain Cancers | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoid Tumor | Carcinoma | Ductal Carcinoma | Genetics | Melanoma | Neurology | OBGYN | Occupational Health | Serous Carcinoma | Skin Cancer